MedTrace Logo

The Effects of Progressive Muscle Relaxation Therapy in Patients With Schizophrenia

NCT03667729 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2018-09-12

No results posted yet for this study

Summary

This study applied a randomized parallel case-controlled design. The study purpose was to evaluate the effects of progressive muscle relaxation on anxiety, psychiatric symptoms and quality of life among patients with chronic schizophrenia compared with an active control.

Conditions

  • Affective Disorders
  • Psychotic Disorder

Interventions

BEHAVIORAL

progressive muscle relaxation

intervention group: The experimental group received muscle relaxation training once a week for 3 consecutive months. The results were measured and followed up after 3 months.

Sponsors & Collaborators

  • Taipei Medical University

    lead OTHER

Principal Investigators

  • hsiu-ju Chang, PHD · Taipei Medical University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2015-06-29
Completion
2015-06-29

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03667729 on ClinicalTrials.gov